BIRC7 (Baculoviral IAP Repeat Containing 7) - Gene Overview

BIRC7, also known as Livin or ML-IAP, is a member of the inhibitor of apoptosis protein (IAP) family, implicated in cancer and apoptosis regulation.

Gene Information Card

Symbol BIRC7
Full Name Baculoviral IAP repeat containing 7
Gene Type protein-coding
Chromosomal Location 20q13.33
NCBI Gene ID 79444 ncbi.nlm.nih.gov/gene/79444
Ensembl ID ENSG00000100906
UniProt ID Q96CA5
OMIM ID 605737
HGNC ID 13549
Aliases Livin, ML-IAP, KIAP, RNF50

Description

BIRC7 (Baculoviral IAP repeat containing 7) encodes a protein belonging to the inhibitor of apoptosis protein (IAP) family. It is a potent anti-apoptotic factor that inhibits caspases, particularly caspase-3, -7, and -9, thereby promoting cell survival. BIRC7 is expressed in various tissues and is overexpressed in many cancers, contributing to tumor progression and resistance to therapy. It also plays a role in immune regulation and cell cycle control.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Overexpression of BIRC7 inhibits apoptosis, promoting tumor cell survival and resistance to chemotherapy. High expression observed in melanoma, lung, breast, and colon cancers (COSMIC, literature).
Autoimmune diseases Dysregulation of BIRC7 may affect immune cell apoptosis, contributing to autoimmune pathology. Expression changes noted in inflammatory conditions (UniProt, literature).
Viral infections Some viruses may modulate BIRC7 to evade host apoptosis, aiding viral persistence. Indirect evidence from studies on viral oncogenesis (NCBI Gene).

Expression Profile

Tissue Expression
Tissue nTPM level
Placenta High High expression
Testis Medium Moderate expression
Fetal tissues Medium Expression in fetal liver and kidney
Adult tissues (most) Low Low or undetectable in normal adult tissues except placenta and testis
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical cancer) High Overexpressed in cancer cell lines
MCF7 (breast cancer) Medium Moderate expression
A549 (lung cancer) High High expression
HCT116 (colon cancer) Medium Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.430G>A (p.Ala144Thr) Missense Rare Potential impact on protein stability (ClinVar)
c.497C>T (p.Pro166Leu) Missense Rare Unknown functional effect (ClinVar)
Copy number gain Amplification Common in tumors Increased expression leading to apoptosis inhibition (COSMIC)
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations are rare and may impair anti-apoptotic activity, potentially increasing apoptosis susceptibility.

Gain of Function (GOF)

Gain-of-function mutations or overexpression enhance anti-apoptotic function, promoting tumor survival.

Dominant Negative (DN)

Dominant-negative effects have not been well characterized for BIRC7.

Gene Ontology (GO)

• apoptotic process • cysteine-type endopeptidase inhibitor activity
• ubiquitin-protein transferase activity • zinc ion binding
• cytoplasm • nucleus

Pathways

• Apoptosis regulation
• NF-kappaB signaling
• Ubiquitin-proteasome pathway

Protein Summary

The BIRC7 protein (Livin) is a 298-amino acid protein containing a single baculoviral IAP repeat (BIR) domain and a RING finger domain. It inhibits apoptosis by binding to caspases and promoting their ubiquitination and degradation. It also participates in NF-kappaB activation and cell cycle regulation. BIRC7 is predominantly expressed in embryonic tissues and certain cancers, making it a potential therapeutic target.

Related Products

Product name Cat.No. Species Gene ID
BIRC7 Knockout HEK293 Cell Line EDJ-KQ12536 Human 79444 Details Get a Quote
BIRC7 Knockout A-549 Cell Line EDJ-KQ41529 Human 79444 Details Get a Quote
BIRC7 Knockout HeLa Cell Line EDJ-KQ57175 Human 79444 Details Get a Quote
BIRC7 Knockout HCT 116 Cell Line EDJ-KQ74108 Human 79444 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: